Newsroom

News and safety alerts

868 items

Announcements, product safety communications and regulatory updates.

Safety Alerts

Safety Updates on COVID-19 Vaccine (Comirnaty®)

Introduction According to World Health Organisation (WHO), vaccination will be an important tool to stop the COVID-19 pandemic. Now, a year after the pandemic erupted, more than 60 COVID-19 vaccine…

Safety Alerts

Mesalazine and sulfasalazine: Nephrolithiasis

Overview Mesalazine and sulfasalazine are anti-inflammatory agents from the 5-aminosalicylic acid (5-ASA) group which are commonly used for the treatment of inflammatory bowel disease (IBD), such as…

Document attached

Safety Alerts

Oseltamivir: Thrombocytopenia

Overview In Malaysia, oseltamivir is generally indicated for treatment and post-exposure prophylaxis of influenza infection for adults and children.1 Oseltamivir is an antiviral drug that acts…

Document attached

Safety Alerts

Abiraterone: Risk of hypoglycaemia due to drug interaction

Overview Abiraterone is an androgen hormone antagonist that helps to reduce the level of testosterone and other androgen hormone in the blood.1 It is indicated with prednisone or prednisolone for…

Document attached

Safety Alerts

Ondansetron: Information updates on risk of birth defects

Overview Ondansetron is a 5-HT3 receptor antagonist indicated for the prevention of nausea and vomiting induced by chemotherapy and radiotherapy. It is also indicated for prevention and treatment of…

Document attached

Announcement Main

MAINTENANCE FOR PAYMENT IN QUEST3+

To all our valued QUEST 3+ users, All online payment transactions which includes payment method using Credit Card (CC), Personal Account (B2C) and Corporate Account (B2B) via the QUEST3+ system will…

Safety Alerts

Propofol: Risk of priapism

Overview Propofol is indicated for the induction and maintenance of general anesthesia or sedation in children and adults during surgical or other diagnostic procedures.1 Currently, there are 10…

Document attached